Press-release for stocks for oncorus, inc. for SRNE

Prices are updated after-hours

Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.02 33.33% -8.85% 97K

| -99.88% | O: -0.48% H: 0.72% C: -1.33%
REPL | $6.33 -1.4% -1.58% 630K

| -81.02% | O: 0.84% H: 3.45% C: 1.78%
ONCR | $0.126 -75.95% 140K

| -98.97% | O: -0.24% H: 1.98% C: -1.74%
immunotherapy therapy cancer

61%

39%

CSSE 4 | $0.4253 179.25% 64.77% 210M

BOF | $2.08 77.78% 41.21% 110M

ILAG | $0.54 12.27% 40.62% 3.7M

LICN | $0.999 78.39% 40.49% 15M

AMST | $3.4 70.0% 39.58% 70M

MTC | $3.6 60.71% 38.04% 9.1M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.458 14.5% 30.92% 91K

WHLM | $6.25 35.87% 28.46% 700K

MULN | News | $3.77 38.1% 27.78% 13M

Save your searches and get alerts when important news are released.